P2Y14R antagonist 4
P2Y14R antagonist 4 (Compound 25l) is an orally active P2Y14R antagonist (IC50: 5.6 nM) with superior binding affinity to P2Y14R over PPTN. P2Y14R antagonist 4 has anti-inflammatory activity and reduces LPS (HY-D1056) -induced proinflammatory cytokines (IL-1β, IL-6, and TNF-α) release[1].
Product Specifications
CAS Number
[3081687-67-1]
UNSPSC
12352005
Target
Interleukin Related; P2Y Receptor
Related Pathways
GPCR/G Protein; Immunology/Inflammation
Field of Research
Inflammation/Immunology
Smiles
OC(C1=CC(C2=CC=C(C3CCNCC3)C=C2)=CC(NS(CCC4=CC=C(C(F)(F)F)C=C4)(=O)=O)=C1)=O
Molecular Formula
C27H27F3N2O4S
Molecular Weight
532.57
References & Citations
[1]Ma S, et al. Discovery of a series of novel 3-sulfonamido benzoic acid derivatives as promising P2Y14R antagonists for acute lung injury. Eur J Med Chem. 2025 Jun 5;290:117588.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
P2Y14 Receptor
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
